End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.22 MYR | -0.81% |
|
-3.94% | -9.63% |
Jul. 10 | Theta Edge Names New Chairman; Shares Rise 3% | MT |
May. 03 | Lotte Chemical Titan Trims Loss in Q1; Shares Drop 3% | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company's share price in relation to its net book value makes it look relatively cheap.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- One of the major weak points of the company is its financial situation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.63% | 595M | C+ | ||
-3.57% | 37.21B | B- | ||
-26.35% | 20.28B | B- | ||
-26.89% | 11.33B | B- | ||
+4.25% | 11.3B | A- | ||
+27.47% | 8.81B | C+ | ||
-21.91% | 8.75B | B+ | ||
-12.15% | 5.47B | C+ | ||
-46.00% | 4.09B | C | ||
-29.31% | 3.35B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- LCTITAN Stock
- Ratings Lotte Chemical Titan Holding